Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia

BACKGROUND: Treatment choice in pediatric immune thrombocytopenia (ITP) is arbitrary, because few studies are powered to identify predictors of therapy response. Increasingly, rituximab is becoming a treatment of choice in those refractory to other therapies. METHODS: The objective of this study was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Grace, Rachael F., Bennett, Carolyn M., Ritchey, A. Kim, Jeng, Michael, Thornburg, Courtney D., Lambert, Michele P., Neier, Michelle, Recht, Michael, Kumar, Manjusha, Blanchette, Victor, Klaassen, Robert J., Buchanan, George R., Kurth, Margaret Heisel, Nugent, Diane J., Thompson, Alexis A., Stine, Kimo, Kalish, Leslie A., Neufeld, Ellis J.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3863944/
https://ncbi.nlm.nih.gov/pubmed/21674758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23130
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars